PTPRC and breast neoplasm: To determine if syndecan‐2 was also expressed in TASCs within human breast tumours, samples of primary tumours obtained during resection surgeries were digested and stained with antibodies against CD45 and syndecan‐2 and then analysed by flow cytometry.